Proactiveinvestors United Kingdom Enertopia Corp https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Enertopia Corp RSS feed en Sun, 21 Jul 2019 16:01:24 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[Media files - Canadian mine developer Enertopia Corp (CNSX:TOP) talks about the latest lithium boom ]]> https://www.proactiveinvestors.co.uk/companies/stocktube/5429/canadian-mine-developer-enertopia-corp-cnsxtop-talks-about-the-latest-lithium-boom-5429.html Mon, 22 Aug 2016 16:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/stocktube/5429/canadian-mine-developer-enertopia-corp-cnsxtop-talks-about-the-latest-lithium-boom-5429.html <![CDATA[News - Enertopia adds Amazon.ca to list of online V-Love retailers ]]> https://www.proactiveinvestors.co.uk/companies/news/108777/enertopia-adds-amazonca-to-list-of-online-v-love-retailers-108777.html Beginning today, shoppers can purchase Enertopia’s (CSE:TOP) (OTCBB:ENRT) V-Love desire gel for women through Amazon.ca.

Amazon.ca’s main distribution facility in Mississauga, Ontario, has received the first shipment of V-Love and is ready to deliver it to consumers throughout Canada after they order it online by going to amazon.ca, entering vlove in the search field and completing a purchase order.

V-Love is also available online through the London Drugs website, www.londondrugs.com as well as in stores operated by the popular drugstore chain.

"We are very pleased to now have two major channels for online distribution in Canada as we move forward with our consumer outreach programs," stated Enertopia’s president Robert McAllister.

V-Love, the inaugural product in Enertopia’s health and wellness line, first went on sale in May of this year when the company debuted the product with a special launch at Loblaws City Market in North Vancouver.  Enertopia worked with sexual health expert Maureen McGrath, who hosts the Sunday Night Sex Show on Vancouver’s CKNW radio, on development of the gel.

]]>
Tue, 07 Jul 2015 21:31:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/108777/enertopia-adds-amazonca-to-list-of-online-v-love-retailers-108777.html
<![CDATA[News - 30 London Drugs retail outlets already carrying Enertopia’s V-Love ]]> https://www.proactiveinvestors.co.uk/companies/news/108561/30-london-drugs-retail-outlets-already-carrying-enertopias-v-love-108561.html Beginning today, shoppers can find Enertopia’s (CSE:TOP) (OTCBB:ENRT) V-Love desire gel for women in 30 London Drugs stores. All 79 stores operated by the popular drugstore chain should have the product on-shelf by July 3.

V-Love will also be made available online through the London Drugs website, www.londondrugs.com. 

"We are very pleased to be in a growing number of stores and look forward to growing our V-Love brand name," said Enertopia’s president Robert McAllister in a press release Monday.

Founded in 1945, London Drugs offers consumers a range of products from digital cameras and cosmetics to computers and televisions, though pharmacy and health care services are the heart of its business.  Its stores are prominent in both urban centers and suburban communities, with locations in British Columbia, Alberta, Saskatchewan and Manitoba.

V-Love, the inaugural product in Enertopia’s health and wellness line, first went on sale in May of this year when the company debuted the product with a special launch at Loblaws City Market in North Vancouver.

Separately, Enertopia said Friday that it had signed a definitive agreement to sell its wholly owned subsidiary Thor Pharma Corp. and its related Marihuana for Medical Purposes Regulations (MMPR) application covering a facility in Burlington, Ontario.

]]>
Tue, 30 Jun 2015 17:21:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/108561/30-london-drugs-retail-outlets-already-carrying-enertopias-v-love-108561.html
<![CDATA[News - Enertopia says London Drugs to carry V-Love desire gel at all 79 locations ]]> https://www.proactiveinvestors.co.uk/companies/news/108271/enertopia-says-london-drugs-to-carry-v-love-desire-gel-at-all-79-locations-108271.html Enertopia (CSE:TOP) (OTCBB:ENRT) has taken a major step forward with the marketing of its new V-Love desire gel by signing a distribution deal that will see the product go on sale in all 79 stores operated by London Drugs, one of the most popular retailers in Western Canada.

The British Columbia-based drugstore chain, which also has stores in Alberta, Saskatchewan and Manitoba, has already received the first shipment of V-Love at its main distribution facility in Richmond, BC, Enertopia said Monday.  V-Love will also be available online through the London Drugs website, www.londondrugs.com.

"We are very pleased to be working with London Drugs, a respected community leader and name synonymous with consumer products,” said Enertopia’s president, Robert McAllister.

Founded in 1945, London Drugs offers consumers a range of products from digital cameras and cosmetics to computers and televisions, though pharmacy and health care services are the heart of its business.  Its stores are prominent in both urban centers and suburban communities.

V-Love, the inaugural product in Enertopia’s health and wellness line, first went on sale in May of this year when the company debuted the product with a special launch at Loblaws City Market in North Vancouver.  Sales topped 150 units from the launch on May 9 through the end of that month.

Enertopia worked with sexual health expert Maureen McGrath, who hosts the Sunday Night Sex Show on Vancouver’s CKNW radio, on the development of V-Love.  The topical gel V-Love enhances sexual pleasure by lubricating and providing a feeling of natural vaginal moisture.

]]>
Mon, 22 Jun 2015 21:23:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/108271/enertopia-says-london-drugs-to-carry-v-love-desire-gel-at-all-79-locations-108271.html
<![CDATA[News - Enertopia puts brakes on medical marijuana ambitions to focus on nearer-term opportunities ]]> https://www.proactiveinvestors.co.uk/companies/news/108226/enertopia-puts-brakes-on-medical-marijuana-ambitions-to-focus-on-nearer-term-opportunities-108226.html Enertopia Corporation (CSE:TOP) (OTCBB:ENRT) has signed a binding Letter of Intent to sell wholly owned subsidiary Thor Pharma Corp. and its related Marihuana for Medical Purposes Regulations (MMPR) application covering a facility in Burlington, Ontario, the company said in a statement Friday.

The Burlington application and associated rights, co-owned by Enertopia and Lexaria Corp. (OTCQB:LXRP) (CSE:LXX) under a joint venture agreement, could generate up to $1,500,000 in milestone payments should the facility become licensed under the MMPR program.  Any payments would be split approximately 50/50 between Lexaria and Enertopia.

Separately, Enertopia and The Green Canvas Ltd. have mutually agreed to terminate their joint venture covering a proposed 14,000 sq. ft medical marijuana production facility in Saskatchewan.  As a result, 6,400,000 Enertopia common shares held in escrow by The Green Canvas will be returned to the corporate treasury and cancelled.

The announcement reflects the company’s decision to prioritize business opportunities in the health and wellness segment that offer potential for near-term cash flow and require moderate investment.

License approvals under the Canadian system regulating production of medical marijuana have slowed owing both to the large number of applications received by Health Canada and uncertainty resulting from ongoing court cases.  Enertopia decided that it was not in the best interests of shareholders to pursue medical marijuana growing opportunities at this time given the associated financial obligations.

"The Company has completed two milestones in building a stable foundation with its ownership of 1,000,000 shares in Lexaria Corp.which has just filed PCT for patent pending bio technologies and the potential of approximately $750,000 in future payments from the Burlington application," Enertopia President Robert McAllister said.

As part of its strategic shift, the company last month initiated sales of a new product in the sexual health sector called V-Love.  Enertopia said in a recent press release that sales of V-Love, a desire gel for women, at the Loblaws City Market in North Vancouver where it debuted had exceeded expectations, topping 150 units from the launch on May 9 through the end of that month.

Online sales of V-Love are set to begin soon, and McAllister said talks are ongoing with a number of potential retailers to carry the product.

Enertopia said in its press release that it will remain an advocate for responsible use of medical marijuana in Canada and retains the intention to one day become a licensed producer.

]]>
Mon, 15 Jun 2015 20:52:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/108226/enertopia-puts-brakes-on-medical-marijuana-ambitions-to-focus-on-nearer-term-opportunities-108226.html
<![CDATA[News - V-Love launch gives Enertopia good start in health and wellness sector ]]> https://www.proactiveinvestors.co.uk/companies/news/108209/v-love-launch-gives-enertopia-good-start-in-health-and-wellness-sector-108209.html Enertopia’s (OTCQB:ENRT) (CSE:TOP) V-Love desire gel for women hit store shelves in May, three months to the day after the company partnered with well-known sexual health expert Maureen McGrath and announced its intention to develop a new product to help women reinvigorate their sexual interest.  In line with its strategy to test-market and then gradually ramp up distribution, V-Love went on sale at Loblaws City Market in North Vancouver on May 9, complete with a launch party and an educational session on women’s health.

So far the results have been promising.  With over 150 units sold during the month of May, the company issued a press release this week indicating that demand in the first month had exceeded expectations.  “Our early number is several times what a major chain said we would have to hit on a monthly basis to be considered as a vendor, so we are very pleased,” said Robert McAllister, Enertopia’s President and CEO, via telephone.

In February, Enertopia announced plans to shift its focus to the health and wellness sector, reacting to a longer-than-anticipated timeframe for obtaining a production license for a medical marijuana facility in Ontario.

V-Love is the company’s first product in its health and wellness line.  A topical gel designed to increase women’s sexual interest and desire, the active ingredients increase blood flow to the female genitalia.  V-Love also acts as a lubricant to enhance comfort during intercourse.

McGrath, who hosts the popular Sunday Night Sex Show on Vancouver’s CKNW Radio and has a background in research and product development, participated directly in the creation of V-Love.   She also helped Enertopia create a product platform based on educating women about understanding sexual desire and sexual health in general.

According to McGrath, at the moment there is not a single product on the market approved by the US Food and Drug Administration (FDA) to address low sexual desire for women, although last week one did clear a major hurdle by winning the recommendation of an FDA advisory committee.  In comparison, there are 26 medications approved for male sexual dysfunction.

As a registered nurse in the field of sexual health with her own private practice, McGrath knew what consumers needed in a new sexual desire gel.  Water-based, V-Love is edible and has been tested for latex condom compatibility, relying on L-arginine and vitamin E to help improve elasticity, keep tissue youthful, increase blood flow and enhance lubrication.

An amino acid contained in watermelon and cucumbers, L-arginine has been shown to boost blood flow when applied, which may enhance the sexual pleasure for women.

McGrath said she has received hundreds of inquiries based on discussion of the product on her radio show and has even been recognized and quizzed on it when walking in public.

“A lot of women have low sexual desire and increased blood flow helps with swelling of a woman’s genitalia, including the clitoris.  Vaginal lubrication begins which decreases friction and can make sex more pleasurable,” she explained.

A sought after public speaker and commentator on women’s issues, McGrath agreed to develop V-Love because, she says, “Low sexual desire is growing at an epidemic rate.  We need to re-socialize women around their sexuality and V-Love is a product that can help to do that by raising awareness about female sexual health.”

One takeaway from McGrath’s statement is that it's not all about the money.  And this is reflected in the product’s pricing.  Retailing in the $18-20 dollar range, V-Love is priced as a premium product that provides Enertopia with a healthy margin, while still offering tremendous value to its users given the condition it seeks to address.

Although it might be marketed as such, V-Love is not just for women, according to McGrath.  When it comes to sexual desire, women are more complex than men, she explained.  ”By educating men that self stimulation is also important for women and that V-Love may help with increasing blood flow and decreasing friction, men can learn what it takes to make a sexual experience that’s more satisfying for both partners.  This is a pivotal time in history for female sexuality.  Finally, women are ready to embrace their sexuality and talk about a subject that until recently has been considered quite taboo.”

With a good start under its belt, Enertopia is negotiating with several retailers in Western Canada in an effort to get V-Love into more stores.  Plans also call for initiating online sales in the near future.  “We think online sales will be very important because not everyone will live near a store that carries the product,” explains McAllister.

Canada is the focus for the time being, and as V-Love is just getting under way on the sales front there are plenty of markets nationally to keep the Enertopia team busy for the foreseeable future.  That having been said, the company intends to introduce a V-Love product in other markets that is infused with hemp oil-derived cannabidiols, which are known to have antioxidant and other desirable properties.

“If we can show with our efforts in Canada that there is a consistently strong market for V-Love at a certain price point, then expansion into other markets would just come as a natural extension,” commented McAllister, who made it clear he won’t put the cart before the horse.  “We know we have to walk before we can run.”

]]>
Wed, 10 Jun 2015 16:28:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/108209/v-love-launch-gives-enertopia-good-start-in-health-and-wellness-sector-108209.html